| CONTENTS |
| Achieving the Potential of Nasal Drug Delivery Dr Shunji Haruta, Executive Officer, General Manager, NDS Division SNBL Ltd |
| Technology Profile: Aptar Pharma’s Twister Inhaler |
| Intranasal Vaccine Delivery – A Promising Future Dr Tim Wolfe, Medical Adviser, LMA Atomization Wolfe Tory Medical, Inc |
| Company Profile teamtechnik Group |
| Conference Preview – Respiratory Drug Delivery (RDD) Conferences & Web Services Dr Richard Dalby, Professor of Pharmaceutical Sciences University of Maryland School of Pharmacy |
| Technology Profile Aptar Pharma’s DF30Plus |
| Filling Dry-Powder Inhalers: a Paradigm Shift with Fill2Weight Tom Bailey, Managing Director Dr Dave Seaward, Projects Director 3P Innovation Ltd |
| Conference Review – Drug Delivery to the Lungs 22 (DDL 22) Guy Furness, Publisher ONdrugDelivery |
| Computational Modelling for Dry-Powder Inhalers Ralf Kröger, Marc Horner & Robert Woolhouse ANSYS Inc Michael Becker & Herbert Wachtel Boehringer Ingelheim Pharma GmbH & Co KG Anne De Boer University of Groningen |
| Company Profile Phillips-Medisize |